These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 22968785

  • 1. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.
    Davis VL, Shaikh F, Gallagher KM, Villegas M, Rea SL, Cline JM, Hughes CL.
    Horm Cancer; 2012 Dec; 3(5-6):227-39. PubMed ID: 22968785
    [Abstract] [Full Text] [Related]

  • 2. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice.
    Wong AW, Dunlap SM, Holcomb VB, Nunez NP.
    Alcohol Clin Exp Res; 2012 Apr; 36(4):577-87. PubMed ID: 21981381
    [Abstract] [Full Text] [Related]

  • 3. Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.
    Herynk MH, Lewis MT, Hopp TA, Medina D, Corona-Rodriguez A, Cui Y, Beyer AR, Fuqua SA.
    Oncogene; 2009 Sep 10; 28(36):3177-87. PubMed ID: 19561644
    [Abstract] [Full Text] [Related]

  • 4. Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
    Zhang C, Mori M, Gao S, Li A, Hoshino I, Aupperlee MD, Haslam SZ, Xiao H.
    Cancer Res; 2010 Dec 15; 70(24):10224-33. PubMed ID: 21159643
    [Abstract] [Full Text] [Related]

  • 5. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 6. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
    Hewitt SC, Bocchinfuso WP, Zhai J, Harrell C, Koonce L, Clark J, Myers P, Korach KS.
    Cancer Res; 2002 May 15; 62(10):2798-805. PubMed ID: 12019156
    [Abstract] [Full Text] [Related]

  • 7. Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.
    Davis VL, Newbold RR, Couse JF, Rea SL, Gallagher KM, Hamilton KJ, Goulding EH, Jefferson W, Eddy EM, Bullock BC, Korach KS.
    Reprod Toxicol; 2012 Dec 15; 34(4):512-21. PubMed ID: 22989549
    [Abstract] [Full Text] [Related]

  • 8. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA.
    Breast Cancer Res; 2011 Jan 28; 13(1):R11. PubMed ID: 21276249
    [Abstract] [Full Text] [Related]

  • 9. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
    Jacquemart IC, Springs AE, Chen WY.
    Int J Oncol; 2009 Feb 28; 34(2):517-28. PubMed ID: 19148488
    [Abstract] [Full Text] [Related]

  • 10. Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
    Ma Z, Parris AB, Xiao Z, Howard EW, Kosanke SD, Feng X, Yang X.
    J Exp Clin Cancer Res; 2017 Jan 06; 36(1):6. PubMed ID: 28061785
    [Abstract] [Full Text] [Related]

  • 11. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.
    Cancer Res; 2007 Sep 15; 67(18):8671-81. PubMed ID: 17875707
    [Abstract] [Full Text] [Related]

  • 12. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD, Seachrist DD, Abdul-Karim FW, Keri RA.
    Oncogene; 2006 Jun 01; 25(23):3325-34. PubMed ID: 16434967
    [Abstract] [Full Text] [Related]

  • 13. Soy isoflavones increase latency of spontaneous mammary tumors in mice.
    Jin Z, MacDonald RS.
    J Nutr; 2002 Oct 01; 132(10):3186-90. PubMed ID: 12368416
    [Abstract] [Full Text] [Related]

  • 14. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
    Shepherd TG, Kockeritz L, Szrajber MR, Muller WJ, Hassell JA.
    Curr Biol; 2001 Nov 13; 11(22):1739-48. PubMed ID: 11719215
    [Abstract] [Full Text] [Related]

  • 15. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
    Campbell MJ, Wollish WS, Lobo M, Esserman LJ.
    In Vitro Cell Dev Biol Anim; 2002 Jun 13; 38(6):326-33. PubMed ID: 12513120
    [Abstract] [Full Text] [Related]

  • 16. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours.
    Davies MP, Rudland PS, Robertson L, Parry EW, Jolicoeur P, Barraclough R.
    Oncogene; 1996 Oct 17; 13(8):1631-7. PubMed ID: 8895508
    [Abstract] [Full Text] [Related]

  • 17. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL.
    Oncogene; 2001 Sep 20; 20(42):6009-17. PubMed ID: 11593408
    [Abstract] [Full Text] [Related]

  • 18. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
    Little JL, Serzhanova V, Izumchenko E, Egleston BL, Parise E, Klein-Szanto AJ, Loudon G, Shubina M, Seo S, Kurokawa M, Ochs MF, Golemis EA.
    Oncogene; 2014 Jan 23; 33(4):411-20. PubMed ID: 23318423
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice.
    Nair HB, Perla RP, Kirma NB, Krishnegowda NK, Ganapathy M, Rajhans R, Nair SS, Saikumar P, Vadlamudi RK, Tekmal RR.
    Horm Cancer; 2012 Apr 23; 3(1-2):26-36. PubMed ID: 22006184
    [Abstract] [Full Text] [Related]

  • 20. In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk.
    Ma Z, Parris AB, Howard EW, Davis M, Cao X, Woods C, Yang X.
    Int J Mol Sci; 2020 Apr 28; 21(9):. PubMed ID: 32353937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.